Mahyco inks deal with Kenyan government to export GM cotton seeds, JK Agri Genetics finds Ethiopian Bt cotton market.
New Delhi: As Genetically Modified (GM) seeds continue to remain blocked by activism of the left and the right, and fears of science, Indian seed companies that have suffered policy indecision are now beginning to find captive markets overseas, especially in fast-growing Africa.
One of India’s largest seed companies, Maharashtra Hybrid Seeds Co. Ltd (Mahyco) has entered into a contract with the Kenyan government to export GM cotton seeds. Mahyco has initiated various field trials currently being conducted in Mwea, Bura, Katumani, Kampi ya mawe and Perkerra, said sources.
Mahyco has a joint venture with Bt seeds pioneer Monsanto called Mahyco Monsanto Biotech. Mahyco sub-licenses BT cotton technology in India through its collaboration with the US-based firm, acquired by Bayer last month.
Interestingly, the Kenyan government had banned the import of GM crops in November 2012, but with this contract, the ban has been lifted. Mahyco will supply the seeds to Kenya’s farmers with commercialisation expected in the next two years, added sources.
The Jalna-based company produces seeds for cotton, wheat, rice and sorghum, among others.
Earlier this year, another Indian company JK Agri Genetics Ltd was contracted by the Ethiopian government for the import of Bt Cotton Seeds.
We are deeply grateful to our readers & viewers for their time, trust and subscriptions.
Quality journalism is expensive and needs readers to pay for it. Your support will define our work and ThePrint’s future.
Issues in India
Indian seed companies’ expansion overseas comes in the backdrop of vehement opposition to GM crops by several sections, including environmentalists and members of the civil society, the Swadeshi Jagran Manch which is close to the Rashtriya Swayamsevak Sangh (RSS) and an establishment suspicious of biotech.
Last year, Mahyco talked about reducing research in GM crops in India and looking for markets overseas where it can take its technologies.
In April this year, the Delhi high court ruled that Monsanto cannot claim patents on its GM cotton seeds. The company has appealed the ruling in the Supreme Court.
In October 2016, the government told the Supreme Court that it would not release GM mustard without the court’s nod, about a fortnight after the court asked the Centre to hold its release for 10 days. The court’s direction came in response to a petition filed by activist Aruna Rodrigues seeking prohibition of open field trials and commercial release of GM mustard.
Developed by Monsanto, Bt cotton was the first GM crop to be approved for cultivation in India in 2002.
“The seed companies are being vilified in India because GM research has been painted in negative light. This, even though they are simply catering to the agricultural sector by seeking to supply highly productive seed variety,” said biotech champion C.S. Prakash, professor of plant genetics, biotechnology and genomics at Tuskegee University, US. “Look at how Bt cotton has been a success story. While these seed companies are vilified in India for selling GM seeds, they are now sought after globally. Them turning to overseas markets is a logical step given they don’t see a future here.”
News media is in a crisis & only you can fix it
You are reading this because you value good, intelligent and objective journalism. We thank you for your time and your trust.
You also know that the news media is facing an unprecedented crisis. It is likely that you are also hearing of the brutal layoffs and pay-cuts hitting the industry. There are many reasons why the media’s economics is broken. But a big one is that good people are not yet paying enough for good journalism.
We have a newsroom filled with talented young reporters. We also have the country’s most robust editing and fact-checking team, finest news photographers and video professionals. We are building India’s most ambitious and energetic news platform. And we aren’t even three yet.
At ThePrint, we invest in quality journalists. We pay them fairly and on time even in this difficult period. As you may have noticed, we do not flinch from spending whatever it takes to make sure our reporters reach where the story is. Our stellar coronavirus coverage is a good example. You can check some of it here.
This comes with a sizable cost. For us to continue bringing quality journalism, we need readers like you to pay for it. Because the advertising market is broken too.
If you think we deserve your support, do join us in this endeavour to strengthen fair, free, courageous, and questioning journalism, please click on the link below. Your support will define our journalism, and ThePrint’s future. It will take just a few seconds of your time.